About Intellectual Property IP Training Respect for IP IP Outreach IP for… IP and... IP in... Patent & Technology Information Trademark Information Industrial Design Information Geographical Indication Information Plant Variety Information (UPOV) IP Laws, Treaties & Judgements IP Resources IP Reports Patent Protection Trademark Protection Industrial Design Protection Geographical Indication Protection Plant Variety Protection (UPOV) IP Dispute Resolution IP Office Business Solutions Paying for IP Services Negotiation & Decision-Making Development Cooperation Innovation Support Public-Private Partnerships AI Tools & Services The Organization Working with WIPO Accountability Patents Trademarks Industrial Designs Geographical Indications Copyright Trade Secrets WIPO Academy Workshops & Seminars IP Enforcement WIPO ALERT Raising Awareness World IP Day WIPO Magazine Case Studies & Success Stories IP News WIPO Awards Business Universities Indigenous Peoples Judiciaries Genetic Resources, Traditional Knowledge and Traditional Cultural Expressions Economics Gender Equality Global Health Climate Change Competition Policy Sustainable Development Goals Frontier Technologies Mobile Applications Sports Tourism PATENTSCOPE Patent Analytics International Patent Classification ARDI – Research for Innovation ASPI – Specialized Patent Information Global Brand Database Madrid Monitor Article 6ter Express Database Nice Classification Vienna Classification Global Design Database International Designs Bulletin Hague Express Database Locarno Classification Lisbon Express Database Global Brand Database for GIs PLUTO Plant Variety Database GENIE Database WIPO-Administered Treaties WIPO Lex - IP Laws, Treaties & Judgments WIPO Standards IP Statistics WIPO Pearl (Terminology) WIPO Publications Country IP Profiles WIPO Knowledge Center WIPO Technology Trends Global Innovation Index World Intellectual Property Report PCT – The International Patent System ePCT Budapest – The International Microorganism Deposit System Madrid – The International Trademark System eMadrid Article 6ter (armorial bearings, flags, state emblems) Hague – The International Design System eHague Lisbon – The International System of Appellations of Origin and Geographical Indications eLisbon UPOV PRISMA UPOV e-PVP Administration UPOV e-PVP DUS Exchange Mediation Arbitration Expert Determination Domain Name Disputes Centralized Access to Search and Examination (CASE) Digital Access Service (DAS) WIPO Pay Current Account at WIPO WIPO Assemblies Standing Committees Calendar of Meetings WIPO Webcast WIPO Official Documents Development Agenda Technical Assistance IP Training Institutions COVID-19 Support National IP Strategies Policy & Legislative Advice Cooperation Hub Technology and Innovation Support Centers (TISC) Technology Transfer Inventor Assistance Program WIPO GREEN WIPO's Pat-INFORMED Accessible Books Consortium WIPO for Creators WIPO Translate Speech-to-Text Classification Assistant Member States Observers Director General Activities by Unit External Offices Job Vacancies Procurement Results & Budget Financial Reporting Oversight
Arabic English Spanish French Russian Chinese
Laws Treaties Judgments Browse By Jurisdiction

Directive No. 2004/27/EC of the European Parliament and of the Council of 31 March 2004 of 31 March 2004 amending Directive 2001/83/EC on the Community code relating to medicinal products for human use, European Union (EU)

Back

Latest Version in WIPO Lex
Year of Version 2004 Dates Entry into force: April 30, 2004 Adopted: March 31, 2004 Type of Text IP-related Laws   Subject Matter Patents (Inventions) Subject Matter (secondary) Other Notes The notification by the European Union to the WTO under Article 63.2 of TRIPS states:
'Directive No. 2004/27/EC amends definitions and scope of Directive 2001/83/EC, as well as containing provisions on Marketing Authorisation Procedures, in order to further harmonize the legislation on medicinal products for human use and achieve the objective of free and safe movement of medicinal products for human use and the elimination of obstacles to trade of such products in the internal market.'

Available Texts Main text(s) Main text(s) French Directive n° 2004/27/CE du Parlement européen et du Conseil du 31 mars 2004 modifiant la directive n° 2001/83/CE instituant un code communautaire relatif aux médicaments à usage humain PDF HTML English Directive No. 2004/27/EC of the European Parliament and of the Council of 31 March 2004 of 31 March 2004 amending Directive 2001/83/EC on the Community code relating to medicinal products for human use PDF HTML Spanish Directiva N° 2004/27/CE del Parlamento Europeo y del Consejo de 31 de marzo de 2004, que modifica la Directiva N° 2001/83/CE por la que se establece un Código Comunitario sobre Medicamentos de Uso Humano PDF HTML
Legislation Amends (1 text(s)) Amends (1 text(s))
Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use (EU173)
 Is implemented by (6 text(s)) Is implemented by (6 text(s))
Patents Act (1967:837) (as amended up to Order (2023:216)) (SE235)
Act No. 378/2007 Coll. of 6 December 2007 on Pharmaceuticals and on Amendments to Some Related Acts (the Act on Pharmaceuticals) (as amended up to Act No. 262/2019 Coll.) (CZ114)
Trademarks Act (2010:1877) (as amended up to Act (2020:545))  (SE221)
The Consolidate Patents Act (Consolidate Act No. 90 of January 29, 2019) (DK212)
Medical Products Act (HR096)
Federal Law on Amendments to the Law on Patents 1970 and the Law on Utility Models (BGBl. I No. 130/2005) (AT153)
WTO Document Reference
IP/N/1/EU/1
IP/N/1/EU/U/1
IP/N/1/EU/17
IP/N/1/EU/U/4
WIPO Lex No. EU175